Global Biosimilar Drug Sales Market Report Forecast 2017 to 2022

July 2017 | 118 pages | ID: G485B02ABD1EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
company 5
company 6
company 7
company 8
company 9

Product Segment Analysis:
Injection
Tablets
Others

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
  It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 BIOSIMILAR DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Biosimilar Drug
1.2 Classification of Biosimilar Drug
  1.2.1 Injection
  1.2.2 Tablets
  1.2.3 Others
1.3 Application of Biosimilar Drug
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Biosimilar Drug Market States Status and Prospect (2012-2022) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Biosimilar Drug (2012-2022)
  1.5.1 Global Biosimilar Drug Sales and Growth Rate (2012-2022)
  1.5.2 Global Biosimilar Drug Revenue and Growth Rate (2012-2022)

2 GLOBAL ECONOMIC IMPACT ON BIOSIMILAR DRUG INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 BIOSIMILAR DRUG MANUFACTURING COST ANALYSIS

3.1 Biosimilar Drug Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Biosimilar Drug

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Biosimilar Drug Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2016
4.4 Downstream Buyers

5 GLOBAL BIOSIMILAR DRUG COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Biosimilar Drug Market Competition by Manufacturers
  5.1.1 Global Biosimilar Drug Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Biosimilar Drug Revenue and Share by Manufacturers (2012-2017)
5.2 Global Biosimilar Drug (Volume and Value) by Type
  5.5.1 Global Biosimilar Drug Sales and Market Share by Type (2012-2017)
  5.5.2 Global Biosimilar Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Biosimilar Drug (Volume and Value) by Regions
  5.3.1 Global Biosimilar Drug Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Biosimilar Drug Revenue and Market Share by Regions (2012-2017)
5.4 Global Biosimilar Drug (Volume) by Application

6 UNITED STATES BIOSIMILAR DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 United States Biosimilar Drug Sales and Value (2012-2017)
  6.1.1 United States Biosimilar Drug Sales and Growth Rate (2012-2017)
  6.1.2 United States Biosimilar Drug Revenue and Growth Rate (2012-2017)
  6.1.3 United States Biosimilar Drug Sales Price Trend (2012-2017)
6.2 United States Biosimilar Drug Sales and Market Share by Manufacturers
6.3 United States Biosimilar Drug Sales and Market Share by Type
6.4 United States Biosimilar Drug Sales and Market Share by Application

7 CHINA BIOSIMILAR DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 China Biosimilar Drug Sales and Value (2012-2017)
  7.1.1 China Biosimilar Drug Sales and Growth Rate (2012-2017)
  7.1.2 China Biosimilar Drug Revenue and Growth Rate (2012-2017)
  7.1.3 China Biosimilar Drug Sales Price Trend (2012-2017)
7.2 China Biosimilar Drug Sales and Market Share by Manufacturers
7.3 China Biosimilar Drug Sales and Market Share by Type
7.4 China Biosimilar Drug Sales and Market Share by Application

8 EUROPE BIOSIMILAR DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Biosimilar Drug Sales and Value (2012-2017)
  8.1.1 Europe Biosimilar Drug Sales and Growth Rate (2012-2017)
  8.1.2 Europe Biosimilar Drug Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Biosimilar Drug Sales Price Trend (2012-2017)
8.2 Europe Biosimilar Drug Sales and Market Share by Manufacturers
8.3 Europe Biosimilar Drug Sales and Market Share by Type
8.4 Europe Biosimilar Drug Sales and Market Share by Application

9 JAPAN BIOSIMILAR DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Biosimilar Drug Sales and Value (2012-2017)
  9.1.1 Japan Biosimilar Drug Sales and Growth Rate (2012-2017)
  9.1.2 Japan Biosimilar Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Biosimilar Drug Sales Price Trend (2012-2017)
9.2 Japan Biosimilar Drug Sales and Market Share by Manufacturers
9.3 Japan Biosimilar Drug Sales and Market Share by Type
9.4 Japan Biosimilar Drug Sales and Market Share by Application

10 GLOBAL BIOSIMILAR DRUG MANUFACTURERS ANALYSIS

10.1 CP Guojian Pharma
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Biotech Pharma
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Celgen Pharma
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Henlius
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 company
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 company
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 company
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 company
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 company
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL BIOSIMILAR DRUG MARKET FORECAST (2017-2022)

13.1 Global Biosimilar Drug Sales, Revenue Forecast (2017-2022)
13.2 Global Biosimilar Drug Sales Forecast by Regions (2017-2022)
13.3 Global Biosimilar Drug Sales Forecast by Type (2017-2022)
13.4 Global Biosimilar Drug Sales Forecast by Application (2017-2022)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biosimilar Drug
Table Classification of Biosimilar Drug
Figure Global Sales Market Share of Biosimilar Drug by Type in 2016
Table Applications of Biosimilar Drug
Figure Global Sales Market Share of Biosimilar Drug by Application in 2016
Figure United States Biosimilar Drug Revenue and Growth Rate (2012-2022)
Figure China Biosimilar Drug Revenue and Growth Rate (2012-2022)
Figure Europe Biosimilar Drug Revenue and Growth Rate (2012-2022)
Figure Japan Biosimilar Drug Revenue and Growth Rate (2012-2022)
Figure Global Biosimilar Drug Sales and Growth Rate (2012-2022)
Figure Global Biosimilar Drug Revenue and Growth Rate (2012-2022)
Table Global Biosimilar Drug Sales of Key Manufacturers (2012-2017)
Table Global Biosimilar Drug Sales Share by Manufacturers (2012-2017)
Figure 2015 Biosimilar Drug Sales Share by Manufacturers
Figure 2016 Biosimilar Drug Sales Share by Manufacturers
Table Global Biosimilar Drug Revenue by Manufacturers (2012-2017)
Table Global Biosimilar Drug Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Biosimilar Drug Revenue Share by Manufacturers
Table 2016 Global Biosimilar Drug Revenue Share by Manufacturers
Table Global Biosimilar Drug Sales and Market Share by Type (2012-2017)
Table Global Biosimilar Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Biosimilar Drug by Type (2012-2017)
Figure Global Biosimilar Drug Sales Growth Rate by Type (2012-2017)
Table Global Biosimilar Drug Revenue and Market Share by Type (2012-2017)
Table Global Biosimilar Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimilar Drug by Type (2012-2017)
Figure Global Biosimilar Drug Revenue Growth Rate by Type (2012-2017)
Table Global Biosimilar Drug Sales and Market Share by Regions (2012-2017)
Table Global Biosimilar Drug Sales Share by Regions (2012-2017)
Figure Sales Market Share of Biosimilar Drug by Regions (2012-2017)
Figure Global Biosimilar Drug Sales Growth Rate by Regions (2012-2017)
Table Global Biosimilar Drug Revenue and Market Share by Regions (2012-2017)
Table Global Biosimilar Drug Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Biosimilar Drug by Regions (2012-2017)
Figure Global Biosimilar Drug Revenue Growth Rate by Regions (2012-2017)
Table Global Biosimilar Drug Sales and Market Share by Application (2012-2017)
Table Global Biosimilar Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Biosimilar Drug by Application (2012-2017)
Figure Global Biosimilar Drug Sales Growth Rate by Application (2012-2017)
Figure United States Biosimilar Drug Sales and Growth Rate (2012-2017)
Figure United States Biosimilar Drug Revenue and Growth Rate (2012-2017)
Figure United States Biosimilar Drug Sales Price Trend (2012-2017)
Table United States Biosimilar Drug Sales by Manufacturers (2012-2017)
Table United States Biosimilar Drug Market Share by Manufacturers (2012-2017)
Table United States Biosimilar Drug Sales by Type (2012-2017)
Table United States Biosimilar Drug Market Share by Type (2012-2017)
Table United States Biosimilar Drug Sales by Application (2012-2017)
Table United States Biosimilar Drug Market Share by Application (2012-2017)
Figure China Biosimilar Drug Sales and Growth Rate (2012-2017)
Figure China Biosimilar Drug Revenue and Growth Rate (2012-2017)
Figure China Biosimilar Drug Sales Price Trend (2012-2017)
Table China Biosimilar Drug Sales by Manufacturers (2012-2017)
Table China Biosimilar Drug Market Share by Manufacturers (2012-2017)
Table China Biosimilar Drug Sales by Type (2012-2017)
Table China Biosimilar Drug Market Share by Type (2012-2017)
Table China Biosimilar Drug Sales by Application (2012-2017)
Table China Biosimilar Drug Market Share by Application (2012-2017)
Figure Europe Biosimilar Drug Sales and Growth Rate (2012-2017)
Figure Europe Biosimilar Drug Revenue and Growth Rate (2012-2017)
Figure Europe Biosimilar Drug Sales Price Trend (2012-2017)
Table Europe Biosimilar Drug Sales by Manufacturers (2012-2017)
Table Europe Biosimilar Drug Market Share by Manufacturers (2012-2017)
Table Europe Biosimilar Drug Sales by Type (2012-2017)
Table Europe Biosimilar Drug Market Share by Type (2012-2017)
Table Europe Biosimilar Drug Sales by Application (2012-2017)
Table Europe Biosimilar Drug Market Share by Application (2012-2017)
Figure Japan Biosimilar Drug Sales and Growth Rate (2012-2017)
Figure Japan Biosimilar Drug Revenue and Growth Rate (2012-2017)
Figure Japan Biosimilar Drug Sales Price Trend (2012-2017)
Table Japan Biosimilar Drug Sales by Manufacturers (2012-2017)
Table Japan Biosimilar Drug Market Share by Manufacturers (2012-2017)
Table Japan Biosimilar Drug Sales by Type (2012-2017)
Table Japan Biosimilar Drug Market Share by Type (2012-2017)
Table Japan Biosimilar Drug Sales by Application (2012-2017)
Table Japan Biosimilar Drug Market Share by Application (2012-2017)
Table CP Guojian Pharma Basic Information List
Table CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CP Guojian Pharma Biosimilar Drug Global Market Share (2012-2017)
Table Biotech Pharma Basic Information List
Table Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biotech Pharma Biosimilar Drug Global Market Share (2012-2017)
Table Celgen Pharma Basic Information List
Table Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Celgen Pharma Biosimilar Drug Global Market Share (2012-2017)
Table Henlius Basic Information List
Table Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Henlius Biosimilar Drug Global Market Share (2012-2017)
Table company 5 Basic Information List
Table company 5 Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 5 Biosimilar Drug Global Market Share (2012-2017)
Table company 6 Basic Information List
Table company 6 Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 6 Biosimilar Drug Global Market Share (2012-2017)
Table company 7 Basic Information List
Table company 7 Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 7 Biosimilar Drug Global Market Share (2012-2017)
Table company 8 Basic Information List
Table company 8 Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 8 Biosimilar Drug Global Market Share (2012-2017)
Table company 9 Basic Information List
Table company 9 Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 9 Biosimilar Drug Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Drug
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Biosimilar Drug Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2016
Table Major Buyers of Biosimilar Drug
Table Distributors/Traders List
Figure Global Biosimilar Drug Sales and Growth Rate Forecast (2017-2022)
Figure Global Biosimilar Drug Revenue and Growth Rate Forecast (2017-2022)
Table Global Biosimilar Drug Sales Forecast by Regions (2017-2022)
Table Global Biosimilar Drug Sales Forecast by Type (2017-2022)
Table Global Biosimilar Drug Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius